PhoenixBio Co Ltd (6190):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:PhoenixBio Co Ltd (6190) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8022
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
PhoenixBio Co Ltd (PhoenixBio) is a life science company that offers medical therapy solutions. The company offers contract study services including dosing of test-compounds, sampling, in-life phase trials, chemical analysis, measurement of human albumin levels, and metabolic enzymes and blood biochemical measurements. It uses PXB-Mouse, a chimeric mouse with a humanized liver for use in drug discovery and early development. PhoenixBio’s study services include DMPK studies; safety studies; viral hepatitis-related studies; efficacy and safety studies for human specific nucleic acids, antibody, or polypeptide medicines; and in vitro studies using fresh human hepatocytes taken from PXB-cells. The company operates in Japan and the US. PhoenixBio is headquartered in Higashihiroshima, Japan.

PhoenixBio Co Ltd (6190) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
PhoenixBio Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
PhoenixBio Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
PhoenixBio Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
PhoenixBio Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
PhoenixBio Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
PhoenixBio Co Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Equity Offering 10
PhoenixBio to Raise USD1.3 Million in Private Placement of Shares 10
PhoenixBio Raises USD6.4 Million in IPO 11
Acquisition 12
PhoenixBio to Acquire KMT Hepatech for USD4.3 Million 12
PhoenixBio Co Ltd – Key Competitors 13
PhoenixBio Co Ltd – Key Employees 14
PhoenixBio Co Ltd – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Recent Developments 16
Corporate Communications 16
Jun 29, 2018: Promotion of New President & CEO of PhoenixBio and PhoenixBio USA – Hiroshima, Japan, June 29th, 2018 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
PhoenixBio Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2018 2
PhoenixBio Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
PhoenixBio Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
PhoenixBio Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
PhoenixBio Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
PhoenixBio Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
PhoenixBio to Raise USD1.3 Million in Private Placement of Shares 10
PhoenixBio Raises USD6.4 Million in IPO 11
PhoenixBio to Acquire KMT Hepatech for USD4.3 Million 12
PhoenixBio Co Ltd, Key Competitors 13
PhoenixBio Co Ltd, Key Employees 14
PhoenixBio Co Ltd, Subsidiaries 15

List of Figures
PhoenixBio Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
PhoenixBio Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
PhoenixBio Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
PhoenixBio Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
PhoenixBio Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
PhoenixBio Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
PhoenixBio Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
PhoenixBio Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[PhoenixBio Co Ltd (6190):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • SolarCity Corporation-エネルギー分野:企業M&A・提携分析
    Summary SolarCity Corporation (SolarCity), a subsidiary of Tesla, Inc., is a vertically integrated solar energy systems provider that designs, permits, finances, and installs the solar energy and storage systems,. The company also performs maintenance and monitoring services. It procures various com …
  • Scotiabank Peru S.A.A.
    Scotiabank Peru S.A.A. - Strategy, SWOT and Corporate Finance Report Summary Scotiabank Peru S.A.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Vectren Corp (VVC):電力:M&Aディール及び事業提携情報
    Summary Vectren Corp (Vectren) is an energy holding company, which carries out the distribution and transmission of natural gas and electricity. Under its wholly owned subsidiary, Vectren Utility Holdings, Inc., the company operates three utilities; Vectren Energy Delivery of Indiana - North (Vectre …
  • Cara Therapeutics Inc (CARA):企業の財務・戦略的SWOT分析
    Summary Cara Therapeutics Inc (Cara Therapeutics) is a biotechnology company that develops and commercializes chemical entities for acutepain, chronic pain and pruritus. The company offers kappa opioid receptor agonists in the therapeutic areas of acute pain, chronic pain, neuropathic pain and pruri …
  • Exterran Corp (EXTN):企業の財務・戦略的SWOT分析
    Exterran Corp (EXTN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • China Power Clean Energy Development Co Ltd (735):電力:M&Aディール及び事業提携情報
    Summary China Power Clean Energy Development Co Ltd (CPCE) formerly China Power New Energy Development Co Ltd, is an electric utility. It develops, constructs, owns, operates, and manages clean energy power plants. The company produces electricity through natural gas, wind, hydro, and solar sources. …
  • Ortho-Clinical Diagnostics Inc:企業のM&A・事業提携・投資動向
    Ortho-Clinical Diagnostics Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Ortho-Clinical Diagnostics Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • Slovenske elektrarne, a.s.-エネルギー分野:企業M&A・提携分析
    Summary Slovenske elektrarne, a.s. (Slovenske), is an electric utility company that generates, distributes and trades electricity. It also generates and markets heat and offers ancillary services to the power industry. The company generates electricity through various resources such as conventional …
  • Translate Bio Inc (TBIO):製薬・医療:M&Aディール及び事業提携情報
    Summary Translate Bio Inc (Translate Bio), formerly RaNA Therapeutics Inc is a healthcare service provider that develops therapies which targets RNA within cells in the body to selectively activate protein expression. The company provides platform oligonucleotides (oligos) are molecules designed to …
  • Arotech Corporation:企業の戦略・SWOT・財務情報
    Arotech Corporation - Strategy, SWOT and Corporate Finance Report Summary Arotech Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Just Eat Plc
    Just Eat Plc - Strategy, SWOT and Corporate Finance Report Summary Just Eat Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Chevron Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Chevron Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Chevron Corp (Chevron) is an integrated oil and gas company. It operates in the oil and gas value chain from exploration and production, storage and pipeline transportation to refining, marketing and di …
  • Titan Petrochemicals Group Limited (1192):石油・ガス:M&Aディール及び事業提携情報
    Summary Titan Petrochemicals Group Limited (Titan) is an investment holding company that carries out midstream energy and shipbuilding operations. It provides oil storage, transit, and blending services. The company transports oil and petrochemical products; and supplies oil products. Titan also car …
  • China Power Clean Energy Development Co Ltd (735):企業の財務・戦略的SWOT分析
    China Power Clean Energy Development Co Ltd (735) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …
  • Amneal Pharmaceuticals Inc (AMRX):製薬・医療:M&Aディール及び事業提携情報
    Summary Amneal Pharmaceuticals Inc (Amneal) formerly Amneal Pharmaceuticals LLC, is an integrated specialty pharmaceutical company that produces generic, specialty and biosimilar medicines. Its product portfolio includes generic and specialty drugs in the therapeutic areas of analgesic, antibiotic, …
  • GEA Group Aktiengesellschaft:企業の戦略・SWOT・財務分析
    GEA Group Aktiengesellschaft - Strategy, SWOT and Corporate Finance Report Summary GEA Group Aktiengesellschaft - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Inner Mongolia Yili Industrial Group Co., Ltd.:戦略・SWOT・企業財務分析
    Inner Mongolia Yili Industrial Group Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Inner Mongolia Yili Industrial Group Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, ope …
  • Omnova Solutions Inc (OMN):企業の財務・戦略的SWOT分析
    Omnova Solutions Inc (OMN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • ZF Friedrichshafen AG:企業の戦略的SWOT分析
    ZF Friedrichshafen AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • TS Corp (001790):企業の財務・戦略的SWOT分析
    TS Corp (001790) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆